Becotatug Vedotin Combined With Pucotenlimab for Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma

NCT07632339 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Becotatug Vedotin combined with Pucotenlimab
PROCEDURE: surgery

Sponsor

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University